SB 914
Sets a cap on health benefit plan enrollee cost-sharing for prescription insulin drugs
Sponsor:
LR Number:
4826S.01I
Committee:
Insurance and Banking
Last Action:
2/27/2020 - Second Read and Referred S Insurance and Banking Committee
Journal Page:
S396
Title:
Calendar Position:
Effective Date:
August 28, 2020

Current Bill Summary

SB 914 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of $100 per 30-day supply of a prescription insulin drug.

The act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2021.

This act is similar to HB 1649 (2020), provisions in HB 2682 (2020), provisions in HB 1987 (2020), and provisions in HB 2163 (2020).

ERIC VANDER WEERD

Amendments

No Amendments Found.